Abiopharma

Director Schall Thomas J. 🟢 acquired 21.6K shares of Immuneering Corp (IMRX) at $4.67 Transaction Date: Jan 15, 2026 | Filing ID: 000014

Illumina, Inc. - Illumina secures CMS reimbursement forTruSight™ Oncology Comprehensive, expanding access to precision oncology

New Form 424B5 - Tharimmune, Inc. Filed: 2026-01-20 AccNo: 0001493152-26-002773 Size: 578 KB

(10% Negative) Interpace Biosciences, Inc. (IDXG) Reports Q1 2026 Financial Results

Aytu BioPharma Highlights Opportunity for EXXUATM (gepirone) as New Way to Treat Major Depressive Disorder That Avoids Common Side Effects of Sexual Dysfunction and Significant Weight Gain following launch of EXXUA

New Form SC TO-C - RAPT Therapeutics, Inc. Filed: 2026-01-20 AccNo: 0001193125-26-016042 Size: 70 KB

(99% Neutral) Tivic Health Systems Inc. (TIVC) Provides Update on treatments for future operations

Director Williams Gregg 🟢 acquired 1.7M shares of Vivani Medical, Inc. (VANI) at $1.26 ($2.0M) Transaction Date: Jan 15, 2026 | Filing ID: 000145

(99% Neutral) Synlogic Inc. (SYBX) Files Form 8-K

Abbott receives CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythms

LaPlume Joseph W 🔴 sold 400 shares of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) at $163.72 Transaction Date: Aug 22, 2025 | Filing ID: 000002

Propanc Biopharma Files New Provisional Patent Application for Methods of Producing Trypsinogen & Chymotrypsinogen with IP Australia

Tharimmune, Inc. Announces Pricing of $55 Million Underwritten Registered Offering

(99% Neutral) Oragenics Inc. (OGEN) Files Form 8-K

Aspect Biosystems and Novo Nordisk enter new phase of partnership to develop curative medicines for diabetes